BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16893619)

  • 1. Microencapsulation of drugs by electro-hydro-dynamic atomization.
    Ciach T
    Int J Pharm; 2006 Oct; 324(1):51-5. PubMed ID: 16893619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of monodispersed Taxol-loaded particles using electrohydrodynamic atomization.
    Ding L; Lee T; Wang CH
    J Control Release; 2005 Feb; 102(2):395-413. PubMed ID: 15653160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.
    Felder ChB; Blanco-Príeto MJ; Heizmann J; Merkle HP; Gander B
    J Microencapsul; 2003; 20(5):553-67. PubMed ID: 12909541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplex lattice design for the optimization of the microencapsulation of a water soluble drug using poly(lactic acid) and poly(lactide co-glycolide) copolymer.
    Elkheshen S
    J Microencapsul; 1996; 13(4):447-62. PubMed ID: 8808781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbranched polymers as drug carriers: microencapsulation and release kinetics.
    Suttiruengwong S; Rolker J; Smirnova I; Arlt W; Seiler M; Lüderitz L; Pérez de Diego Y; Jansens PJ
    Pharm Dev Technol; 2006 Feb; 11(1):55-70. PubMed ID: 16544909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrohydrodynamic atomization for biodegradable polymeric particle production.
    Xie J; Lim LK; Phua Y; Hua J; Wang CH
    J Colloid Interface Sci; 2006 Oct; 302(1):103-12. PubMed ID: 16842810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection.
    Gander B; Wehrli E; Alder R; Merkle HP
    J Microencapsul; 1995; 12(1):83-97. PubMed ID: 7730960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray.
    Lee YH; Mei F; Bai MY; Zhao S; Chen DR
    J Control Release; 2010 Jul; 145(1):58-65. PubMed ID: 20346381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading.
    Leelarasamee N; Howard SA; Malanga CJ; Ma JK
    J Microencapsul; 1988; 5(2):147-57. PubMed ID: 3199303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method.
    Uchida T; Yoshida K; Goto S
    J Microencapsul; 1996; 13(2):219-28. PubMed ID: 8999126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrospun fibers of acid-labile biodegradable polymers containing ortho ester groups for controlled release of paracetamol.
    Qi M; Li X; Yang Y; Zhou S
    Eur J Pharm Biopharm; 2008 Oct; 70(2):445-52. PubMed ID: 18603416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly water-soluble drug nanoparticles via solvent evaporation in water-soluble porous polymers.
    Roberts AD; Zhang H
    Int J Pharm; 2013 Apr; 447(1-2):241-50. PubMed ID: 23499755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro degradation and release profiles for Poly-dl-lactide film containing paracetamol.
    Zhou S; Song B; Li X
    J Mater Sci Mater Med; 2007 Aug; 18(8):1623-6. PubMed ID: 17483888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres.
    Lin SY; Chen KS; Teng HH
    J Microencapsul; 1998; 15(3):383-90. PubMed ID: 9608400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles.
    Mallard C; Coudane J; Rault I; Vert M
    J Microencapsul; 2000; 17(1):81-93. PubMed ID: 10670942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.